Optimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trials.

[1]  Guido Ferrari,et al.  Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. , 2013, Immunity.

[2]  Tomer Hertz,et al.  Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V2 , 2012, Nature.

[3]  Jessica B. Graham.  Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial , 2012 .

[4]  W. Blattner,et al.  A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204) , 2011, PloS one.

[5]  Bernard Klein,et al.  Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138− and CD138+ plasma cells , 2010, Haematologica.

[6]  S. Plotkin.  Correlates of Protection Induced by Vaccination , 2010, Clinical and Vaccine Immunology.

[7]  J. Hoxie,et al.  Selective Expansion of HIV-1 Envelope Glycoprotein-Specific B Cell Subsets Recognizing Distinct Structural Elements Following Immunization1 , 2009, The Journal of Immunology.

[8]  B. Haynes,et al.  HIV-1 Envelope Induces Memory B Cell Responses That Correlate with Plasma Antibody Levels after Envelope gp120 Protein Vaccination or HIV-1 Infection1 , 2009, The Journal of Immunology.

[9]  T. Lebien,et al.  B lymphocytes: how they develop and function. , 2008, Blood.

[10]  Nichole E Carlson,et al.  Duration of humoral immunity to common viral and vaccine antigens. , 2007, The New England journal of medicine.

[11]  L. Baddour.  Duration of Humoral Immunity , 2007 .

[12]  Kenneth G. C. Smith,et al.  Competence and competition: the challenge of becoming a long-lived plasma cell , 2006, Nature Reviews Immunology.

[13]  T. Giese,et al.  Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. , 2004, Blood.

[14]  R. Ahmed,et al.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. , 2004, Journal of immunological methods.

[15]  Luis Villarreal,et al.  Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1 , 2003, The Journal of Immunology.

[16]  R. Coffman,et al.  Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions , 2003, Journal of leukocyte biology.

[17]  Andreas Radbruch,et al.  Humoral immunity and long-lived plasma cells. , 2002, Current opinion in immunology.

[18]  G. Bishop,et al.  Molecular Mechanisms of B Lymphocyte Activation by the Immune Response Modifier R-8481 , 2000, The Journal of Immunology.

[19]  T. Waldschmidt,et al.  The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes. , 2000, Cellular immunology.

[20]  S Miltenyi,et al.  Correlation analysis between frequencies of circulating antigen‐specific IgG‐bearing memory B cells and serum titers of antigen‐specific IgG , 1999, European journal of immunology.

[21]  G. Calandra,et al.  Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. , 1996, Vaccine.

[22]  B. Kay,et al.  High-throughput biotinylation of proteins. , 2009, Methods in molecular biology.

[23]  L. McHeyzer-Williams,et al.  Antigen-specific memory B cell development. , 2005, Annual review of immunology.

[24]  A. Billich.  AIDSVAX VaxGen. , 2004, Current opinion in investigational drugs.